Pfizer's gaseous raw materials for pharmaceuticals have successfully passed the on-site registration inspection and GMP compliance check.

Recently, the National Medical Products Administration Food and Drug Inspection Center, in conjunction with the Shandong Provincial Drug Administration, conducted on-site inspections and pre-market GMP compliance checks on the gas raw material drug YP265 project of Shandong Puluo Debao Pharmaceutical Co., Ltd., a subsidiary of Puluo Pharmaceutical. This gas raw material drug product is the first of its kind domestically, and adopts advanced continuous production technology, marking a significant breakthrough for the company in pharmaceutical process innovation.